5 completed. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 2 | Completed 2 |
Follow bleselumab: new trials by email Literature Review of bleselumab trials Research Report on bleselumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients Bleselumab, Basiliximab, Mycophenolate Mofetil (MMF) - Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS) | Phase 2 | Completed | Astellas Pharma Global Development, Inc. | 67 | 2017-05-22 | 2024-12-04 |
| A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients ASKP1240, Tacrolimus, Mycophenolate Mofetil (MMF) - Kidney Transplantation | Phase 2 | Completed | Astellas Pharma Global Development, Inc. | 149 | 2013-03-05 | 2025-11-21 |
| A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis ASKP1240, Placebo - Psoriasis | Phase 2 | Completed | Astellas Pharma Global Development, Inc. | 60 | 2012-04-30 | 2025-11-17 |
| Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240 ASKP1240 - Pharmacokinetics of ASKP1240, Pharmacodynamics of ASKP1240 | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 24 | 2012-02-01 | 2012-12-10 |
| A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney Transplantation bleselumab, Placebo - Kidney Transplantation | Phase 1 | Completed | Astellas Pharma Inc | 50 | 2010-11-17 | 2025-11-17 |
Psoriasis (1) · Skin Diseases (1)
Astellas Pharma Global Development, Inc. (4) · Astellas Pharma Inc (1)
United States (4) · Canada (2) · Australia (1) · New Zealand (1)